Case 2: 3—cv—05400—MRP—JEM Document 247 Filed 03/26/15 Page 1 of 6 Page ID #27546
`
`3
`
`4
`
`DURIE TANGRI LLP
`1 DARALYN J. DURIE (SBN 169825)
`ddurie@durietangri.com
`DAVID McGOWAN (SBN 154289)
`dmcg0wan@durietangri.com
`ADAM R. BRAUSA (SBN 298754)
`abrausa@durietangri.com
`TIMOTHY C. SAULSBURY (SBN 281434)
`tsau1sbury@durietangri.com
`217 Leidesdorff Street
`San Francisco, CA 94111
`Telephone: 415-362-6666
`Facsimile:
`415-236-6300
`
`6
`
`7
`
`Counsel Continued on Next Page
`
`10
`
`11
`
`UNITED STATES DISTRICT COURT
`
`CENTRAL DISTRICT OF CALIFORNIA
`
`12 BRISTOL-MYERS SQUIBB
`13 COMPANY,
`
`Case No. 2:13-CV-05400-MRP
`
`STIPULATION OF DISMISSAL
`
`14
`
`15
`16
`
`17
`
`Plaintiff and Counter-
`
`OF ENTIRE ACTION
`
`Defendant,
`
`V.
`
`_
`Judge: Hon. Mariana R. Pfaelzer
`Ctrm:
`12
`
`18 GENENTECH, INC. and CITY
`OF HOPE,
`
`Defendants and
`
`Counter-Plaintiffs.
`
`19
`
`20
`
`2 1
`
`22
`
`23
`
`24 MEDAREX, L.L.C.,
`
`Third-Party Defendant
`and Counter-Claimant.
`
`25
`
`26
`
`27
`
`28
`
`
`
`STIPULATION OF DISMISSAL OF ENTIRE ACTION‘,
`CASE NO. 2: 1 3-CV-5400-MRP-JEM
`
`Sanofi/Regeneron Ex. 1058, pg 1283
`
`Mylan Ex. 1053, pg 1233
`
`

`
`Case 2: 3—cv—05400—MRP—JEM Document 247 Filed 03/26/15 Page 2 of 6 Page ID #27547
`
`PAUL, WEISS, RIFKIND,
`WHARTON & GARRISON LLP
`
`KENNETH A. GALLO (pro hac vice)
`kga11o@pau1weiss.com
`2001 K Street, NW
`Washington, DC 20006-1047
`Telephone: 202-223-7300
`Facsimile:
`202-223-7420
`
`MAYER BROWN LLP
`
`ELIZABETH MANN (SBN 106524)
`emann@mayerbrown.com
`350 S. Grand Avenue, 25th Floor
`Los Angeles, CA 90071
`Telephone:
`(213) 229-9500
`Facsimile:
`(213) 625-0248
`
`ERIC ALAN STONE (pro hac vice)
`estone@pau1weiss.com
`KIRA A. DAVIS (pro hac vice)
`kdavis@pau1weiss.com
`1285 Avenue of the Americas
`
`New York, NY 10019-6064
`Telephone: 212-373-3000
`Facsimile:
`212-757-3990
`
`LISA M. FERRI (pro hac vice)
`lferri@mayerbrown.com
`RICHARD J. McCORMICK
`
`(pro hac vice)
`rmccorrnick@mayerbrown.com
`1221 Avenue of the Americas
`
`New York, New York 10020
`Telephone:
`(212) 506-2500
`Facsimile:
`(212) 262 1910
`
`Attorneys for Defendants and Counter-
`Plaintiffs GENENTECH, INC. and
`CITY OF HOPE
`
`Attorneys for Plaintiff and Counter-
`Defendant BRISTOL-MYERS SQUIBB
`COMPANY and Third Party Defendant
`and Counter-Claimant
`
`IRELL & MANELLA LLP
`
`MEDAREX, L.L.C.
`
`DAVID I. GINDLER (SBN 117824)
`dgind1er@ire11.com
`JOSEPH M. LIPNER (SBN 155735)
`j1ipner@ire11.com
`1800 Avenue of the Stars, Suite 900
`Los Angeles, CA 90067-4276
`Telephone: 310-277-1010
`Facsimile 310-203-7199
`
`Attorneys for Defendant and Counter-
`Plaintiff CITY OF HOPE
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`STIPULATION OF DISMISSAL OF ENTIRE ACTION;
`CASE NO. 2: 1 3-CV-5400-MRP-JEM
`
`Sanofi/Regeneron Ex. 1058, pg 1284
`
`Mylan Ex. 1053, pg 1234
`
`

`
`Case 2: 3—cv—05400—MRP—JEM Document 247 Filed 03/26/15 Page 3 of 6 Page ID #27548
`
`1
`
`IT IS HEREBY STIPULATED by and among the parties to this action
`
`through their counsel that the above-captioned action (including without limitation
`
`all claims, counterclaims, and third-party claims asserted in the action) be and
`
`hereby is dismissed in its entirety pursuant to Federal Rule of Civil Procedure
`
`4 l(a)(l)(A)(ii).
`
`IT IS FURTHER STIPULATED by and among the parties to this action
`
`through their counsel that:
`
`1. This dismissal is without prejudice with respect to Counts III and IV of
`
`Genentech Inc. ’s and City of Hope’s First Amended Counterclaims to
`
`Bristol-Myers Squibb Company’s Complaint for Declaratory Judgment,
`
`dated November 8, 2013, for “Infiingement of the Cabilly II Patent
`
`regarding Erbitux (Asserted Against BMS)” (Count III) and
`
`“Infringement of the Cabilly III Patent regarding Erbitux (Asserted
`
`Against BMS)” (Count IV), which allege that by marketing and
`
`distributing ErbituX® (cetuximab) in the United States, offering for sale
`
`and selling ErbituX® in the United States, and/or importing ErbituX® into
`
`the United States, BMS has infringed, is infringing, and/or will infringe
`
`one or more of the claims of the Cabilly II and/or Cabilly III patents,
`
`literally and/or under the doctrine of equivalents.
`
`2. This dismissal is with prejudice with respect to all other all claims,
`
`counterclaims, and third-party claims asserted in the action, including all
`
`claims, counterclaims, and third-party claims asserted in the action
`
`regarding Yervoy® (ipilimumab).
`
`3. Nothing in this Stipulation shall affect in any way any rights, claims,
`
`counterclaims, defenses, or affirmative defenses of any of the parties
`
`hereto in Case No. 2: 13-cv-07248-MRP-JEM, Eli Lilly and Company and
`
`Imclone Systems LLC v. Genentech, Inc. and City 0fH0pe (C.D. Cal.).
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`1
`
`STIPULATION OF DISMISSAL OF ENTIRE ACTION;
`CASE NO. 2: 1 3-CV-5400-MRP-JEM
`
`Sanofi/Regeneron Ex. 1058, pg 1285
`
`Mylan Ex. 1053, pg 1235
`
`

`
`Case 2: 3—cv—05400—MRP—JEM Document 247 Filed 03/26/15 Page 4 of 6 Page ID #27549
`
`IT IS SO STIPULATED.
`
`Dated: March 26, 2015
`
`DURIE TANGRI LLP
`
`BY3
`
`/s/ Daralyn J. Durie
`
`Daralyn J. Durie
`
`Attorneys for Genentech, Inc.
`
`PAUL, WEISS, RIFKIND, WHARTON
`& GARRISON LLP
`
`B .
`y‘
`
`By:
`
`By:
`
`/s/ Kenneth A. Gallo
`Kenneth A. Gallo
`
`Attorneys for Genentech, Inc.
`and City of Hope
`
`IRELL AND MANELLA LLP
`
`/s/Jose h M. Li ner
`Joseph M. Lipner
`
`Attorneys for City of Hope
`
`MAYER BROWN LLP
`
`/s/ Lisa M. Ferri
`Lisa M. Ferri
`
`Attorneys for Bristol-Myers Squibb
`Company and Medarex, L.L.C.
`
`2
`
`STIPULATION OF DISMISSAL OF ENTIRE ACTION;
`CASE NO. 2: 1 3-CV-5400-MRP-JEM
`
`Sanofi/Regeneron Ex. 1058, pg 1286
`
`Mylan Ex. 1053, pg 1286
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`12
`
`13
`14
`15
`16
`
`17
`
`18
`19
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`

`
`Case 2: 3—cv—05400—MRP—JEM Document 247 Filed 03/26/15 Page 5 of 6 Page ID #27550
`
`FILER’S ATTESTATION
`
`Pursuant to Civil L.R. 5-4.3.4, regarding signatures, I, Daralyn J. Durie, attest
`
`that concurrence in the filing of this document has been obtained.
`
`/s/ Daral)_/n J. Durie
`DARALYN J. DURIE
`
`2
`
`3
`
`5
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`3
`
`STIPULATION OF DISMISSAL OF ENTIRE ACTION;
`CASE NO. 2: 1 3-CV-5400-MRP-JEM
`
`Sanofi/Regeneron Ex. 1058, pg 1287
`
`Mylan Ex. 1053, pg 1287
`
`

`
`C se 2:13-cv-05400-MRP-JEM Document 247 Filed 03/26/15 Page 6 of 6 Page ID #:7551
`
`CERTIFICATE OF SERVICE
`
`I certify that all counsel of record is being served on March 26, 2015 with a copy of
`
`this document Via the Court’s CM/ECF system.
`
`/s/ Daralyn J. Durie
`DARALYN J. DURIE
`
`1
`
`2
`
`3
`
`\]O\
`
`\O
`
`>— 3
`
`;_a
`
`;_a
`
`[\J>—>—>—>—>—>—>—>—®\OOO\lO‘\Ul-l>UJl\J
`
`l\J >—
`
`l\Jl\J
`
`l\J DJ
`
`l\J-B
`
`l\J U1
`
`l\J O\
`
`l\J \]
`
`l\J O0
`
`STIPULATION OF DISMISSAL OF ENTIRE ACTION/ CASE NO. 2:13-CV-05400 MRP (JEMX)
`
`Sanofi/Regeneron Ex. 1058, pg 1288
`
`Mylan Ex. 1053, pg 1288